Literature DB >> 21908505

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

D A Eichenauer1, A Engert, M Dreyling.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21908505     DOI： 10.1093/annonc/mdr378

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  27 in total

Review 1.  Advances in the treatment of Hodgkin lymphoma.

Authors:  Dennis A Eichenauer; Andreas Engert
Journal:  Int J Hematol       Date:  2012-10-11       Impact factor: 2.490

Review 2.  Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy.

Authors:  Ralph M Meyer; Richard T Hoppe
Journal:  Blood       Date:  2012-07-20       Impact factor: 22.113

Review 3.  Role of modern radiation therapy in early stage Hodgkin's lymphoma: A young radiation oncologists' perspective.

Authors:  Andrea Riccardo Filippi; Pierfrancesco Franco; Patrizia Ciammella
Journal:  Rep Pract Oncol Radiother       Date:  2012-07-19

4.  Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.

Authors:  Sally F Barrington; N George Mikhaeel; Lale Kostakoglu; Michel Meignan; Martin Hutchings; Stefan P Müeller; Lawrence H Schwartz; Emanuele Zucca; Richard I Fisher; Judith Trotman; Otto S Hoekstra; Rodney J Hicks; Michael J O'Doherty; Roland Hustinx; Alberto Biggi; Bruce D Cheson
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

Review 5.  Balancing risks and benefits of therapy for patients with favorable-risk limited-stage Hodgkin lymphoma: the role of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy alone.

Authors:  Annette E Hay; Ralph M Meyer
Journal:  Hematol Oncol Clin North Am       Date:  2014-02       Impact factor: 3.722

6.  Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma.

Authors:  Salim Kanoun; Cédric Rossi; Alina Berriolo-Riedinger; Inna Dygai-Cochet; Alexandre Cochet; Olivier Humbert; Michel Toubeau; Emmanuelle Ferrant; François Brunotte; René-Olivier Casasnovas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-09       Impact factor: 9.236

7.  Severe neurotoxicity due to Vinblastine in Hodgkin lymphoma.

Authors:  Pandalanghat Suresh; Rajan Kapoor; B N Kapur
Journal:  South Asian J Cancer       Date:  2014-04

Review 8.  Brentuximab vedotin: a review of its use in patients with hodgkin lymphoma and systemic anaplastic large cell lymphoma following previous treatment failure.

Authors:  Karly P Garnock-Jones
Journal:  Drugs       Date:  2013-03       Impact factor: 9.546

9.  Characterizing bone marrow involvement in Hodgkin's lymphoma by FDG-PET/CT.

Authors:  Michal Weiler-Sagie; Olga Kagna; Eldad J Dann; Ayelet Ben-Barak; Ora Israel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-26       Impact factor: 9.236

10.  Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients.

Authors:  Michel Meignan; Myriam Sasanelli; René Olivier Casasnovas; Stefano Luminari; Federica Fioroni; Chiara Coriani; Helene Masset; Emmanuel Itti; Paolo G Gobbi; Francesco Merli; Annibale Versari
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-26       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.